The FDA approved an allogeneic cord-blood-based cell therapy for people with blood cancers.
Read the full post on Becker's Hospital Review - Healthcare News
The FDA approved an allogeneic cord-blood-based cell therapy for people with blood cancers.
Read the full post on Becker's Hospital Review - Healthcare News